Navigation Links
Clinical Research Staffing Firm ASG Acquires CRO Ockham Development Group
Date:3/2/2009

Merger provides additional value to clients, shareholders and employees

CARY, N.C., March 2 /PRNewswire/ -- ASG, Inc. - a high-quality functional outsourcing and specialty staffing services group based in Cary, North Carolina - has acquired neighboring Ockham Development Group, Inc., a full-service contract research organization.

The acquisition - completed in early February for an undisclosed amount of stock - enables ASG to expand the breadth and value of services it provides clients needing to outsource clinical research trials; it also equips its clients in the pharmaceutical industry with a robust package of functional outsourcing and staffing services as well as a new opportunity to outsource an entire clinical trial.

"The addition of the Ockham team and its services helps accelerate our goal of becoming the company of choice for those wishing to outsource or augment staffing of a clinical trial," said ASG President and CEO James Baker. "We now have the breadth of services that allows clients to one-stop shop if they so desire."

In completing the acquisition, ASG is fulfilling a portion of its global growth strategy that will allow the firm to provide solutions that best meet the needs of existing and potential clients. At the same time, the acquisition will make it possible for Ockham - which will continue to be independently branded - to serve a wider and larger client base.

"The ASG platform will make it possible for Ockham to scale its operations and extend its client reach into a true global presence," said Ockham CEO, Dr. Josh Baker (unrelated), who now leads the company's clinical research organization operations. "This is a unique opportunity to combine with a stable industry leader and quickly build market value."

About ASG:

ASG provides high-quality functional outsourcing and specialty staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. Strategically organized to meet the demands of the marketplace, ASG provides flexible solutions that satisfy client needs through highly experienced recruiting and dedicated functional support teams located throughout the world. http://www.asg-inc.com

About Ockham Development Group:

Ockham Development Group Inc. is a privately held contract research organization headquartered in Cary, North Carolina. Staffed by veteran industry professionals with a track record of proven results, it is centrally located near the university-technology-biotech / pharmaceutical sciences nexus known internationally as Research Triangle Park (RTP).


'/>"/>
SOURCE ASG, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
2. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
3. Implicit Licenses Clinical Stage Antibody Program From Lilly
4. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
5. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
6. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
7. M2S Expert gives address "Applying the Principles of Six Sigma in the Imaging Core Lab" at Imaging for Clinical Trials conference
8. Histogen to Present Preliminary Hair Regrowth Clinical Results at Stem Cell Summit
9. AstraZeneca Implements Customized Cytel East(R) Software for More Accurate Trial Monitoring and Clinical Data Analysis
10. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
11. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... -- Aratana Therapeutics, Inc. (NASDAQ: PETX ), ... and commercialization of innovative biopharmaceutical products for companion animals, ... North America 2016. ... the FDA approval of three innovative therapeutics in 2016, ... oral solution) and NOCITA ® (bupivacaine liposome injectable ...
(Date:1/20/2017)... http://www.Financialbuzz.com - According ... causes of death worldwide. There were 8.2 million cancer ... related deaths increased gradually over time, the death rates ... various cancers continues to drive demand of biological therapies ... Market Insights, Inc. cancer biological therapy market size was USD ...
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
Breaking Biology Technology:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con múltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ...
(Date:12/16/2016)... Research and Markets has announced the addition of the "Biometric ... to their offering. ... The biometric vehicle access system market, in terms of value, ... to 2021. The market is estimated to be USD 442.7 Million ... The growth of the biometric vehicle access system market is fueled ...
(Date:12/15/2016)... BADEN-BADEN, Germany , December 15, 2016 /PRNewswire/ ... services provider, today announced an agreement with NuData Security, ... join forces. The partnership will enable clients to focus on ... with local data protection regulation. ... In order to provide a one-stop ...
Breaking Biology News(10 mins):